drugset / Trial / NCT06941480
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to find out whether 177Lu-DTPA-SC16.56 is a safe treatment for people with small-cell lung cancer or neuroendocrine prostate cancer
Timeline
- Start
- 2026-06
- Primary completion
- 2030-05
- Completion
- 2030-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-DTPA-SC16.56 | Unknown | — | — |